Skip to main content
logo
Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
162.70
+5.22 (3.31%)
Jun 1, 2026, 1:26 PM EDT - Market open

Revolution Medicines Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---11.5835.3829.39
Revenue Growth (YoY)
----67.27%20.38%-31.62%
Gross Profit
---11.5835.3829.39
Selling, General & Admin
261.28195.0497.375.6240.5930.45
Research & Development
1,126987.33592.23423.14253.07186.95
Total Operating Expenses
1,3871,182689.52498.77293.66217.4
Operating Income
-1,387-1,182-689.52-487.19-258.28-188.01
Interest Income
85.2990.6986.8847.489.150.93
Interest Expense
-35.56-24.23----
Other Non-Operating Income (Expense)
-34.6-15.41.8-0.19--0.01
Total Non-Operating Income (Expense)
5.0751.0788.6847.299.150.92
Pretax Income
-1,372-1,131-600.85-439.89-249.13-187.09
Provision for Income Taxes
---0.75-3.52-0.42-
Net Income
-1,372-1,131-600.09-436.37-248.71-187.09
Net Income to Common
-1,372-1,131-600.09-436.37-248.71-187.09
Shares Outstanding (Basic)
1931901681138173
Shares Outstanding (Diluted)
1931901681138173
Shares Change (YoY)
11.34%13.35%48.24%40.34%10.74%32.68%
EPS (Basic)
-7.07-5.95-3.58-3.86-3.08-2.57
EPS (Diluted)
-7.07-5.95-3.58-3.86-3.08-2.57
Shares Outstanding
200.18197185.9164.6890.4174.14
Free Cash Flow
-1,072-913.73-567.74-358.3-235.22-153.71
Free Cash Flow Per Share
-5.55-4.81-3.38-3.17-2.92-2.11
Gross Margin
---100.00%100.00%100.00%
Operating Margin
----4207.12%-730.01%-639.70%
Profit Margin
----3768.28%-702.95%-636.58%
FCF Margin
----3094.14%-664.83%-522.99%
EBITDA
-1,378-1,174-681.9-481.08-253.24-183.86
EBITDA Margin
----4154.36%-715.77%-625.57%
EBIT
-1,387-1,182-689.52-487.19-258.28-188.01
EBIT Margin
----4207.12%-730.01%-639.70%
Effective Tax Rate
-0.00%0.13%0.80%0.17%0.00%
SEC Filings: 10-K · 10-Q